Blockade of the CD47/SIRPα Checkpoint Potentiates the Anti-Tumor Efficacy of Tafasitamab

被引：3
|
作者：
Mangelberger, Doris
Augsberger, Christian
Landgraf, Karin
Heitmuller, Christina
Steidl, Stefan
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139582
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Cancer Therapy Targeting CD47/SIRPα
    Dizman, Nazli
    Buchbinder, Elizabeth I.
    CANCERS, 2021, 13 (24)
  • [32] Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy
    Krishnamoorthy, Mithunah
    Seelige, Ruth
    Brown, Christopher R.
    Chau, Nancy
    Viller, Natasja Nielsen
    Johnson, Lisa D. S.
    Linderoth, Emma
    Wang, Jean C. Y.
    Dillon, Christopher P.
    Abayasiriwardana, Keith
    Lees, Clare
    Wong, Mark
    Kaneda, Megan M.
    Uger, Robert A.
    Lin, Gloria H. Y.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [33] Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
    Johanna Theruvath
    Marie Menard
    Benjamin A. H. Smith
    Miles H. Linde
    Garry L. Coles
    Guillermo Nicolas Dalton
    Wei Wu
    Louise Kiru
    Alberto Delaidelli
    Elena Sotillo
    John L. Silberstein
    Anna C. Geraghty
    Allison Banuelos
    Molly Thomas Radosevich
    Shaurya Dhingra
    Sabine Heitzeneder
    Aidan Tousley
    John Lattin
    Peng Xu
    Jing Huang
    Nicole Nasholm
    Andy He
    Tracy C. Kuo
    Emma R. B. Sangalang
    Jaume Pons
    Amira Barkal
    Rachel E. Brewer
    Kristopher D. Marjon
    Jose G. Vilches-Moure
    Payton L. Marshall
    Ricardo Fernandes
    Michelle Monje
    Jennifer R. Cochran
    Poul H. Sorensen
    Heike E. Daldrup-Link
    Irving L. Weissman
    Julien Sage
    Ravindra Majeti
    Carolyn R. Bertozzi
    William A. Weiss
    Crystal L. Mackall
    Robbie G. Majzner
    Nature Medicine, 2022, 28 : 333 - 344
  • [34] Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
    Tracy C. Kuo
    Amy Chen
    Ons Harrabi
    Jonathan T. Sockolosky
    Anli Zhang
    Emma Sangalang
    Laura V. Doyle
    Steven E. Kauder
    Danielle Fontaine
    Sangeetha Bollini
    Bora Han
    Yang-Xin Fu
    Janet Sim
    Jaume Pons
    Hong I. Wan
    Journal of Hematology & Oncology, 13
  • [35] Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
    Kuo, Tracy C.
    Chen, Amy
    Harrabi, Ons
    Sockolosky, Jonathan T.
    Zhang, Anli
    Sangalang, Emma
    Doyle, Laura, V
    Kauder, Steven E.
    Fontaine, Danielle
    Bollini, Sangeetha
    Han, Bora
    Fu, Yang-Xin
    Sim, Janet
    Pons, Jaume
    Wan, Hong, I
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [36] Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
    Theruvath, Johanna
    Menard, Marie
    Smith, Benjamin A. H.
    Linde, Miles H.
    Coles, Garry L.
    Dalton, Guillermo Nicolas
    Wu, Wei
    Kiru, Louise
    Delaidelli, Alberto
    Sotillo, Elena
    Silberstein, John L.
    Geraghty, Anna C.
    Banuelos, Allison
    Radosevich, Molly Thomas
    Dhingra, Shaurya
    Heitzeneder, Sabine
    Tousley, Aidan
    Lattin, John
    Xu, Peng
    Huang, Jing
    Nasholm, Nicole
    He, Andy
    Kuo, Tracy C.
    Sangalang, Emma R. B.
    Pons, Jaume
    Barkal, Amira
    Brewer, Rachel E.
    Marjon, Kristopher D.
    Vilches-Moure, Jose G.
    Marshall, Payton L.
    Fernandes, Ricardo
    Monje, Michelle
    Cochran, Jennifer R.
    Sorensen, Poul H.
    Daldrup-Link, Heike E.
    Weissman, Irving L.
    Sage, Julien
    Majeti, Ravindra
    Bertozzi, Carolyn R.
    Weiss, William A.
    Mackall, Crystal L.
    Majzner, Robbie G.
    NATURE MEDICINE, 2022, 28 (02) : 333 - +
  • [37] The CD47-SIRPα Immune Checkpoint
    Logtenberg, Meike E. W.
    Scheeren, Ferenc A.
    Schumacher, Ton N.
    IMMUNITY, 2020, 52 (05) : 742 - 752
  • [38] Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
    Lian, Shu
    Xie, Xiaodong
    Lu, Yusheng
    Jia, Lee
    ONCOTARGETS AND THERAPY, 2019, 12 : 9105 - 9114
  • [39] Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer
    Huang, Xiting
    Wang, Qian
    Nan, Yanyang
    Zhang, Xuyao
    Xu, Ke
    Ju, Dianwen
    Ding, Weihong
    BIOMEDICINES, 2024, 12 (09)
  • [40] Targeting CD47 in Sezary syndrome with SIRPαFc
    Johnson, Lisa D. S.
    Banerjee, Swati
    Kruglov, Oleg
    Viller, Natasja Nielsen
    Horwitz, Steven M.
    Lesokhin, Alexander
    Zain, Jasmine
    Querfeld, Christiane
    Chen, Robert
    Okada, Craig
    Sawas, Ahmed
    O'Connor, Owen A.
    Sievers, Eric L.
    Shou, Yaping
    Uger, Robert A.
    Wong, Mark
    Akilov, Oleg E.
    BLOOD ADVANCES, 2019, 3 (07) : 1145 - 1153
12345